SYNTARA LIMITED
ASX:SNTPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 96.2% of what they think they own, once every option and right converts.
Share count grew 43% in 24 months; runway 4–8 quarters; 2 cash raises in 24 months
SYNTARA LIMITED's ordinary share count rose 43.1% between October 2024 and September 2026, its latest share-count filing, reaching 1.96B shares. Two capital raisings were completed in that period, totalling A$23.8M, with the most recent being an A$8.8M placement and share purchase plan in April 2026. Options and rights on issue could convert into 77M new shares, representing 3.9% of current shares; none are in the money at the current price, and the nearest expiry falls in December 2027. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.
Quick answers · 5
When did SNT last raise capital?
The last capital raise in Syntara's filings is Placement and Share Purchase Plan of $8.8M announced 29 Apr 2026, one of 2 cash raises in 24 months.
How much placement capacity does SNT have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does SNT have?
In its quarterly cash report for the quarter ended 30 June 2026, Syntara reported $13.6M of cash and estimated 3.7 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do SNT's options expire?
Unexercised options and rights equal 3.9% of Syntara's shares on issue; the nearest expiry is Dec 2027.
How much has SNT's share count grown?
Syntara has 1.96B shares on issue as at 28 Oct 2026, up 43.1% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 5 Oct 2026 | 3G · unquoted | SNT : ORDINARY FULLY PAID | 1.96B | Appendix 3G |
| 5 Oct 2026 | 3G · unquoted | SNT : ORDINARY FULLY PAID | 1.96B | Appendix 3G |
| 15 Sept 2026 | 2A · quoted issue | SNT : ORDINARY FULLY PAID | 1.96B | Appendix 2A |
| 2 July 2026 | 2A · quoted issue | SNT : ORDINARY FULLY PAID | 1.96B | Appendix 2A |
| 2 July 2026 | 3G · unquoted | SNT : ORDINARY FULLY PAID | 1.96B | Appendix 3G |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
2 cash raises in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered21.0M · 1.1% of sharesOptions and warrants — they convert when the share price clears their exercise price.
- Condition-triggered56.1M · 2.9% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 21.0M priced, 56.1M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
An exercise price is on record for only 27.2% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $0.018 today. No more priced supply until 3× today’s price, which takes it to 9.0M (0.5% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 56.1M (72.8% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| SNTAAT | Options | Price-triggered | $0.11 | 1 Dec 2027 | 3.0M | Filing |
| SNTAB | Options | Price-triggered | $0.11 | 25 Feb 2028 | 9.0M | Filing |
| SNTAA | Options | Price-triggered | $0.040 | 12 Feb 2029 | 6.0M | Filing |
| SNTAAU | Options | Price-triggered | $0.049 | 25 Nov 2030 | 3.0M | Filing |
| SNTAAS | Performance rights | Condition-triggered | — | — | 56.1M | Filing Meeting |
34.9M of the 56.1M granted 5 Oct 2026: conditions on continued service. Terms 1.6M of the 56.1M granted 5 Oct 2026: conditions on continued service. Terms | ||||||
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A line under a class is a grant of rights into it, as read from the company’s own filings: its size, any share-price or market-cap hurdles, and the other kinds of condition it carries. A grant is often only part of the class, so its terms say nothing about the rest. Whether a hurdle has been met is not shown.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 24 Nov 2025 | Dr Kathleen Metters | Other | — | 3.0M | — | — | 3Y notice |
| 24 Nov 2025 | Gary Jonathan Phillips | Other incentive | — | 5.7M | — | — | 3Y notice |
| 20 Feb 2025 | Waradana Malitha Hashan De Silva | Buy placement | 9.8M | 3.0M | — | $585k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.